Home > Insider Trading > Inhibrx Biosciences Inc. > Profile

Inhibrx Biosciences Inc. (INBX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Related Insiders

Kimberly Manhard, Director, 2025-05-29
Md Kristiina Vuori, Director, 2025-05-29
Faiz Jon Kayyem, Director, 2025-05-29

Kimberly Manhard, Director, 2025-05-29
Md Kristiina Vuori, Director, 2025-05-29
Faiz Jon Kayyem, Director, 2025-05-29
Douglas Forsyth, Director, 2025-05-29
Kelly Deck, Chief Financial Officer, 2025-04-02
David Matly, President, 2025-04-02
Mark Lappe, Chief Executive Officer, 2024-09-16
Sharon Rose Shabet, , 2024-06-07
Viking Global Opportunities Parent Gp Llc, , 2024-06-07
Viking Global Opportunities Illiquid Investments Sub-Master Lp, , 2024-06-07
Viking Global Opportunities Gp Llc, , 2024-06-07
Viking Global Opportunities Portfolio Gp Llc, , 2024-06-07
C. David Ott, , 2024-06-07
Andreas Ole Halvorsen, , 2024-06-07
Viking Global Investors Lp, , 2024-06-07
Inhibrx, Inc., , 2024-05-31
P. Brendan Eckelman, Chief Scientific Officer, 2024-05-30

Show All Insiders (17)

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Kayyem Director	$14.19	18,750	$266,101.88	69,843	2024-11-20	Filing
Kayyem Director	$14.19	18,750	$266,101.88	69,843	2024-11-20	Filing
Kayyem Director	$14.23	34,843	$495,707.88	51,093	2024-11-19	Filing
Kayyem Director	$14.23	34,843	$495,707.88	51,093	2024-11-19	Filing
Vuori Director	$15.00	6,667	$100,005.00	20,443	2024-10-03	Filing

News See All

Hedge Fund and Insider Trading News: Steve Cohen, Cathie Wood, Caledonia Investments, Vapotherm Inc (VAPO), Inhibrx, Inc. (INBX), and More

The cryptocurrency industry eagerly awaits the next decision from the Securities and Exchange Commission after a U.S. court ruling a week ago regarding Grayscale Investments (GBTC).

Keep Reading →

September 5th, 2023 - Hedge Funds Insider Trading

12 Best High Risk High Reward Stocks To Buy Now

In this piece, we will take a look at the 12 best high risk high reward stocks to buy now.

Keep Reading →

August 31st, 2023 - Hedge Funds News Quantitative Investing

Should You Hold Inhibrx (INBX)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

January 30th, 2023 - Hedge Fund Investor Letters News